Understanding the Cost Drivers of Clinical Trials to Optimise Design Manufacturing & Regulatory Pathways for Efficiency
- Breaking down major cost drivers including CMC development, GMP manufacturing scale-up, patient recruitment, and long-term safety monitoring requirements
- Reducing inefficiencies through smarter trial design, including adaptive protocols, streamlined endpoints, and biomarker-informed patient selection
- Leveraging scalable manufacturing and early regulatory alignment to minimise delays, rework, and costly late-stage development changes